Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: Results of a 28-week double-blind, placebo-controlled study

American Journal of Psychiatry

Volumn 158, Issue 12, 2001, Pages 1974-1981

  Davidson, J ^a   Pearlstein, T ^a   Londborg, P ^a   Brady, K T ^a   Rothbaum, B ^a   Bell, J ^a   Maddock, R ^a   Hegel, M T ^a   Farfel, G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ADULT; AROUSAL; ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SYMPTOMATOLOGY;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PERSONALITY ASSESSMENT; RECURRENCE; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 0035190261     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.12.1974     Document Type: Article

References (45)

1. Posttraumatic stress disorder in an urban population of young adults: Risk factors for chronicity
2. Posttraumatic stress disorder in the National Comorbidity Survey
3. Trauma: Prevalence, impairment, service use, and cost
4. The relationship between trauma, posttraumatic stress disorder, and physical health
5. Somatic symptoms, social support, and treatment-seeking among sexual assault victims
6. Posttraumatic stress disorder in the community: An epidemiological study
7. Posttraumatic stress disorder and functioning and quality of life outcomes in a nationally representative sample of male Vietnam veterans
8. Quality of life and dissociation in anxiety disorder patients with histories of trauma or PTSD
9. Functional impairment and utilization of services associated with posttraumatic stress in the community
10. Brief psychotherapy for posttraumatic stress disorders
11. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: A controlled study
12. Does EMDR work? And if so, why? A critical review of controlled outcome and dismantling research
13. Eye movement desensitization and reprocessing (EMDR): Evaluation of controlled PTSD research
14. Physiological response of combat memories and preliminary treatment outcome in Vietnam veteran PTSD patients treated with direct therapeutic exposure
15. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims
16. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine
17. Treatment of posttraumatic stress disorder with amitriptyline and placebo
18. Fluoxetine in posttraumatic stress disorder
19. Fluoxetine in posttraumatic stress disorder: Randomised, double-blind study
20. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence
21. Sertraline in the treatment of rape victims with posttraumatic stress disorder
22. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder
23. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial
24. Multi-center, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder
25. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression
26. Phenomenology and course of generalised anxiety disorder
27. The long-term course of panic disorder and its predictors
28. Social phobia subtypes in the National Comorbidity Survey
29. A 40-year follow-up of patients with obsessive-compulsive disorder
30. Pharmacotherapy for obsessive-compulsive disorder
31. The long-term treatment of panic disorder
32. Pharmacotherapy of social anxiety disorder
33. Sertraline treatment of posttraumatic stress disorder: Results of a 24-week open-label extension study
34. A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1
35. Psychometric properties of the Clinician-Administered PTSD Scale, CAPS-1
36. Impact of Event Scale: A measure of subjective stress
37. Impact of event scale: A cross validation study and some empirical evidence
38. Assessment of a new self-rating scale for posttraumatic stress disorder
39. Validation of the Davidson trauma scale in a sample of survivors of childhood sexual abuse
40. A rating scale for depression
41. Quality of life enjoyment and satisfaction questionnaire: A new measure
42. Discontinuing antidepressant treatment in major depression
43. Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment